在头癌幸存者中,炎症和晚期系统性毒性之间的循环
Ilaria Mascagni1, Paolo Bossi1
1Department of Biomedical Sciences, Humanitas University, Pieve Emanuele 20072, Italy; Medical Oncology and Hematology Unit, Humanitas Cancer Center, IRCCS Humanitas Research Hospital, Rozzano 20089, Italy.
Critical reviews in oncology/hematology
|May 29, 2025
概括
头癌 (HNC) 幸存者经常面临长期的副作用. 系统性炎症可能导致这些毒性,建议针对性抗炎治疗以改善生活质量.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 癌症的生存率 癌症的生存率
背景情况:
- 头部和部癌症 (HNC) 用手术,化疗和放射治疗来治疗.
- 虽然对大约50%的患者有治愈效果,但HNC治疗会导致显著的长期副作用.
- 这些后果影响了幸存者的生活质量和预期寿命.
研究的目的:
- 审查目前关于HNC幸存者的晚期系统性毒性的证据.
- 检查系统性炎症和这些晚期影响之间的关系.
- 倡导将症状识别为炎症集群,并针对炎症进行治疗.
主要方法:
- 对HNC幸存者的晚期系统毒性研究的文献综述.
- 分析涉及治疗相关后果中的系统性炎症的证据.
- 综合发现,以支持基于集群的,针对炎症的治疗方法.
主要成果:
- 在HNC幸存者的晚期毒性表现为局部和全身症状,包括疲劳,疼痛和认知问题.
- 系统性炎症越来越被认为是这些晚期影响的核心驱动因素.
- 症状通常发生在集群中,这表明有一个共同的潜在炎症机制.
结论:
- 在HNC幸存者的晚期系统性毒性是一个重要的临床挑战.
- 系统性炎症在这些毒性的发展和持续中起着至关重要的作用.
- 为了改善幸存者护理,需要转向识别和治疗这些症状作为炎症集群的范式转变.
相关概念视频
Toxic Reactions: Overview
1.2K
When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.2K
Inflammation
55.5K
Overview
55.5K
The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
Inflammatory Response
8.6K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
8.6K
Biological Effects of Radiation
16.1K
All radioactive nuclides emit high-energy particles or electromagnetic waves. When this radiation encounters living cells, it can cause heating, break chemical bonds, or ionize molecules. The most serious biological damage results when these radioactive emissions fragment or ionize molecules. For example, α and β particles emitted from nuclear decay reactions possess much higher energies than ordinary chemical bond energies. When these particles strike and penetrate matter, they...
16.1K
Cancer Therapies
8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K


